ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 993,96
-0,17%
Dow Jones
44 747,63
0,00%
DAX
21 896,38
-0,08%
Brent Oil
74,625
0,62%
Bitcoin
97 672,32
1,14%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. TELA Bio Inc (TELA) Cours

TELA Bio Inc

TELA Bio Inc (TELA)

NASDAQ
2,76
-0,04
(-1,43%)
Fermé 07 Février 10:00PM
Retardé de 15 minutes
2,76
0,00
( 0,00% )
Avant marché: 1:00PM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
2,76
Prix Achat
1,12
Prix Vente
2,92
Volume échangé
-
0,00 Fourchette du Jour 0,00
2,30 Plage de 52 semaines 7,52
Cap du marché
108,712M
Clôture Veille
2,76
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
173 012
Actions en circulation
39 388 443
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,33
Bénéfice par action (BPA)
-1,18
Chiffre d'affairess
58,45M
Bénéfice net
-46,66M

À propos de TELA Bio Inc

TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of... TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. Show more

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Site Web
www.telabio.com
Siège social
Wilmington, Delaware, USA
Fondé
-
TELA Bio Inc est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker TELA. Le dernier cours de clôture d'TELA Bio était de US$2,76. Au cours de la dernière année, les actions de TELA Bio ont été négociées dans une fourchette de prix de US$ 2,30 à US$ 7,52.

TELA Bio compte actuellement 39 388 443 actions en circulation. La capitalisation boursière d'TELA Bio est de US$108,71 million. TELA Bio a un ratio cours/bénéfice (ratio PE) de -2.33.

TELA Dernières nouvelles

Plus de nouvelles

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Jan. 24, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue...

24 Janvier 2025
GlobeNewswire Inc.

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Dec. 13, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue...

13 Décembre 2024
GlobeNewswire Inc.

TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions...

19 Novembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

07 Novembre 2024
Edgar (US Regulatory)

TELA Bio Reports Third Quarter 2024 Financial Results

MALVERN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) --  TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions...

07 Novembre 2024
GlobeNewswire Inc.

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Nov. 01, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue...

01 Novembre 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

28 Octobre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Octobre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Octobre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Octobre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.114.150943396232.652.872.561430512.73421831CS
4-0.075-2.64550264552.8352.8852.561828122.69192779CS
12-0.29-9.508196721313.053.22.561730122.81908706CS
26-1.46-34.59715639814.224.262.32142262.84695368CS
52-4.11-59.82532751096.877.522.31964793.8666627CS
156-9.11-76.74810446511.8713.372.31210515.8521861CS
260-12.64-82.077922077915.423.5452.3885557.31581889CS

TELA - Frequently Asked Questions (FAQ)

What is the current TELA Bio share price?
The current share price of TELA Bio is US$ 2,76
How many TELA Bio shares are in issue?
TELA Bio has 39 388 443 shares in issue
What is the market cap of TELA Bio?
The market capitalisation of TELA Bio is USD 108,71M
What is the 1 year trading range for TELA Bio share price?
TELA Bio has traded in the range of US$ 2,30 to US$ 7,52 during the past year
What is the PE ratio of TELA Bio?
The price to earnings ratio of TELA Bio is -2,33
What is the cash to sales ratio of TELA Bio?
The cash to sales ratio of TELA Bio is 1,86
What is the reporting currency for TELA Bio?
TELA Bio reports financial results in USD
What is the latest annual turnover for TELA Bio?
The latest annual turnover of TELA Bio is USD 58,45M
What is the latest annual profit for TELA Bio?
The latest annual profit of TELA Bio is USD -46,66M
What is the registered address of TELA Bio?
The registered address for TELA Bio is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the TELA Bio website address?
The website address for TELA Bio is www.telabio.com
Which industry sector does TELA Bio operate in?
TELA Bio operates in the SURGICAL,MED INSTR,APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGOLMGO Global Inc
US$ 0,40
(116,22%)
150,48M
CDTConduit Pharmaceuticals Inc
US$ 3,13
(101,94%)
3,43M
UPCUniverse Pharmaceuticals Inc
US$ 0,2634
(63,60%)
81,6M
RANDRand Capital Corporation
US$ 36,74
(59,67%)
12
ZOOZZOOZ Power Ltd
US$ 3,22
(56,31%)
46
BTMDBiote Corporation
US$ 2,07
(-56,96%)
43
ANIKAnika Therapeutics Inc
US$ 8,00
(-55,03%)
20
EDRYEuroDry Ltd
US$ 6,01
(-45,01%)
4
NKLANikola Corporation
US$ 0,4499
(-40,21%)
3,77M
PFCPremier Financial Corporation
US$ 17,01
(-39,89%)
5
MGOLMGO Global Inc
US$ 0,40
(116,22%)
150,48M
UPCUniverse Pharmaceuticals Inc
US$ 0,2634
(63,60%)
81,6M
NIVFNewGenIvf Group Ltd
US$ 0,19
(22,50%)
33,76M
LTRYLottery com Inc
US$ 1,7306
(22,74%)
27,02M
RIMEAlgorhythm Holdings Inc
US$ 0,0202
(-5,16%)
20,81M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
TELA
TELA Bio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces